ClinConnect ClinConnect Logo
Search / Trial NCT06791577

Bridging the Healing Gap: A Single-Blind Clinical Trial Assessing the Efficacy of Carboxy-gel in Reducing Bruising and Pain Post-Liposuction

Launched by TOTAL DEFINER RESEARCH GROUP · Jan 19, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Carboxytherapy Co2 Lift Body Contouring Liposuction Liposculpture High Definition Liposculpture Patient Outcomes

ClinConnect Summary

This clinical trial, called "Bridging the Healing Gap," is exploring whether a treatment called CO2 Lift can help reduce bruising and pain after liposuction surgery. Researchers want to know if using CO2 Lift leads to less bruising by the seventh day after surgery compared to a placebo treatment (which is just Vaseline) and how it affects patients' pain levels and overall satisfaction with their recovery.

To participate in this study, adults aged 18 to 65 who are scheduled for liposuction (with or without other procedures) may be eligible. However, those who are pregnant, have severe skin issues, or significant health problems won’t qualify. Participants will receive CO2 Lift on one side of their body and Vaseline on the other after surgery, and their recovery will be monitored through photos and pain assessments over the following week. This trial is currently recruiting participants who are looking for ways to enhance their recovery experience after liposuction.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing body contouring procedures (liposuction or liposculpture), either individually or combined with a maximum of two other major aesthetic procedures involving face, breast, or dermo-lipectomy.
  • healthy patients without underlying comorbidities (classified as ASA≤II)
  • Exclusion Criteria:
  • Pregnant patients
  • Known allergy to CO2 Lift or Vaseline
  • History of keloid formation or significant dermatological conditions.
  • Coagulopathy or current use of anticoagulant therapy.
  • Skin disorders related to collagen disease.
  • BMI ≥ 32 kg/m2.

About Total Definer Research Group

Total Definer Research Group is a leading clinical trial sponsor dedicated to advancing medical research and improving patient care through innovative study designs and rigorous methodologies. With a focus on collaboration and transparency, the organization partners with healthcare professionals, institutions, and regulatory bodies to conduct high-quality clinical trials across various therapeutic areas. The group's commitment to ethical practices and patient safety ensures that their research not only meets regulatory standards but also contributes valuable insights to the medical community, ultimately enhancing treatment options and outcomes for patients worldwide.

Locations

Bogota, Dc, Colombia

Sao Paulo, , Brazil

Cuidad De Mexico, Df, Mexico

Mexico City, Df, Mexico

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported